Medical & Clinical Consortium (MCC)

Click Here To EMAIL INQUIRY
Web: http://www.mcctest.com
E-Mail:
Address: 13740 East Nelson Ave., City of Industry, California 91746-2048, USA
Phone: +1-(626)-934-9364, 877-622-8378 | Fax: +1-(626)-934-9384 | Map/Directions >>

Profile: Medical & Clinical Consortium (MCC) manufactures drug of abuse tests, fertility tests, infectious disease and tropical disease rapid tests. We are an FDA rapid test manufacturer. We offer OEM rapid diagnostic kits, urine analysis strips and malaria rapid tests. Our one step multi-drug screen test panel is a lateral flow chromatographic immunoassay for the qualitative detection of single/multiple drugs, and drug metabolites in urine. Our urine adulteration strip is a plastic strip affixed with a chemical impregnated pad capable of detecting creatinine at a cut-off concentration of 20mg/dl. This test is used to obtain a visual, quick and qualitative result for detection of adulteration (dilution) of urine samples prior to drugs of abuse testing.

The company was founded in 1999, has revenues of USD 1-5 Million.

22 Products/Services (Click for related suppliers)

• Amphetamine Enzyme Immunoassay Test (FDA Code: DKZ / 862.3100)

An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.

• Anesthesia Conduction Kit (FDA Code: CAZ / 868.5140)

An anesthesia conduction kit is a device used to administer to a patient conduction, regional, or local anesthesia. The device may contain syringes, needles, and drugs.

• Anesthetic Conduction Needle with/without Introducer (FDA Code: BSP / 868.5150)

An anesthesia conduction needle is a device used to inject local anesthetics into a patient to provide regional anesthesia.

• Barbiturate Enzyme Immunoassay Test (FDA Code: DIS / 862.3150)

A barbiturate test system is a device intended to measure barbiturates, a class of hypnotic and sedative drugs, in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of barbiturate use or overdose and in monitoring levels of barbiturate to ensure appropriate therapy.

• Benzodiazepine Enzyme Immunoassay Test (FDA Code: JXM / 862.3170)

A benzodiazepine test system is a device intended to measure any of the benzodiazepine compounds, sedative and hypnotic drugs, in blood, plasma, and urine. The benzodiazepine compounds include chlordiazepoxide, diazepam, oxazepam, chlorzepate, flurazepam, and nitrazepam. Measurements obtained by this device are used in the diagnosis and treatment of benzodiazepine use or overdose and in monitoring levels of benzodiazepines to ensure appropriate therapy.

• Cannabinoids Enzyme Immunoassay Test (FDA Code: LDJ / 862.3870)

A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds includedelta -9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use.

• Cocaine and Cocaine Metabolites Enzyme Immunoassay Test (FDA Code: DIO / 862.3250)

A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose.

• Drugs of Abuse Multiple Test Kit (FDA Code: MVO)

• E-coli Salmonella Kits

• Ethyl Alcohol Test (FDA Code: DMJ / 862.3040)

An alcohol test system is a device intented to measure alcohol (e.g., ethanol, methanol, isopropanol, etc.) in human body fluids (e.g., serum, whole blood, and urine). Measurements obtained by this device are used in the diagnosis and treatment of alcohol intoxication and poisoning.

• Forensic Evidence Kit

• Metamphetamine Thin Layer Chromatography Test (FDA Code: DJC / 862.3610)

A methamphetamine test system is a device intended to measure methamphetamine, a central nervous system stimulating drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of methamphetamine use or overdose.

• Methadone Enzyme Immunoassay Test (FDA Code: DJR / 862.3620)

A methadone test system is a device intended to measure methadone, an addictive narcotic pain-relieving drug, in serum and urine. Measurements obtained by this device are used in the diagnosis and treatment of methadone use or overdose and to determine compliance with regulations in methadone maintenance treatment.

• Methamphetamine Gas Chromatography Test (FDA Code: LAF / 862.3610)

• Opiates Enzyme Immunoassay Test (FDA Code: DJG / 862.3650)

An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy.

• Phencyclidine Enzyme Immunoassay (FDA Code: LCM)

• Propoxyphene Enzyme Immunoassay (FDA Code: JXN / 862.3700)

A propoxyphene test system is a device intended to measure propoxyphene, a pain-relieving drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of propoxyphene use or overdose or in monitoring levels of propoxyphene to ensure appropriate therapy.

• Salmonella Spp Antigen (FDA Code: GRL / 866.3550)

• Tetrahydrocannabinol Test (FDA Code: DKE / 862.3870)

• Tricyclic Antidepressant Drugs Radioimmunoassay Test (FDA Code: LFG / 862.3910)

A tricyclic antidepressant drugs test system is a device intended to measure any of the tricyclic antidepressant drugs in serum. The tricyclic antidepressant drugs include imipramine, desipramine, amitriptyline, nortriptyline, protriptyline, and doxepin. Measurements obtained by this device are used in the diagnosis and treatment of chronic depression to ensure appropriate therapy.

• Urine Adultration Strips

• Urine Screening Kit (FDA Code: JXA / 866.2660)

A microorganism differentiation and identification device is a device intended for medical purposes that consists of one or more components, such as differential culture media, biochemical reagents, and paper discs or paper strips impregnated with test reagents, that are usually contained in individual compartments and used to differentiate and identify selected microorganisms. The device aids in the diagnosis of disease.